Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Entasis Therapeutics Holdings Inc. | Chief Financial Officer and Chief Business Officer | Employee Stock Option (Right to Buy) | 43.5K | Jul 16, 2021 | Direct | ||
ALBIREO PHARMA, INC. | Director | Stock Option (right to buy) | 0 | Mar 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ALBO | ALBIREO PHARMA, INC. | Mar 2, 2023 | 7 | $0 | 4 | Mar 2, 2023 | Director |
ALBO | ALBIREO PHARMA, INC. | Jun 24, 2022 | 1 | $0 | 4 | Jun 28, 2022 | Director |
ETTX | Entasis Therapeutics Holdings Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 19, 2022 | Chief Financial Officer and Chief Business Officer |
ETTX | Entasis Therapeutics Holdings Inc. | Nov 2, 2021 | 1 | -$10.8K | 4 | Nov 3, 2021 | CFO and Chief Business Officer |
ETTX | Entasis Therapeutics Holdings Inc. | Oct 19, 2021 | 2 | -$12K | 4 | Oct 20, 2021 | Chief Financial Officer and Chief Business Officer |
ETTX | Entasis Therapeutics Holdings Inc. | Jul 16, 2021 | 6 | $0 | 4 | Feb 15, 2022 | Chief Financial Officer and Chief Business Officer |
ALBO | ALBIREO PHARMA, INC. | Jun 24, 2021 | 1 | $0 | 4 | Jun 28, 2021 | Director |